image: Timothy Greenamyre, M.D., Ph.D., Distinguished Professor of Neurology, Love Family Professor of Neurology at the University of Pittsburgh.
Credit: University of Pittsburgh
J. Timothy Greenamyre, Distinguished Professor of Neurology, University of Pittsburgh School of Medicine, is a recipient of a $9 million grant from Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research, titled “Environmental Exposures and PD Heterogeneity: Mechanisms and Therapeutic Mitigation.”
The project will aim to determine how various environmental exposures cause neurodegeneration and to develop methods to prevent or mitigate these exposures.
Greenamyre is also director of the Pittsburgh Institute for Neurodegenerative Diseases, where the project is based, with investigators from the Department of Neurology and the Department of Pharmacology and Chemical Biology. The research group also includes scientists from Rutgers University, University of Alabama Birmingham, Acurex Biosciences and King’s College London.
They have been selected to join the Collaborative Research Network (CRN), an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson’s disease.
ASAP is expanding the CRN to map the biological blueprint of Parkinson’s disease and build a standardized toolkit of global research resources needed to turn discoveries into treatments. This next phase of the initiative focuses on understanding the heterogeneity of Parkinson’s disease, why it varies across individuals, and advancing discoveries toward more precise diagnostics and future therapies. This effort includes the generation of novel resources for the global research community to work from a common, high-quality baseline, reducing the technical hurdles that stall drug development.
To learn more about the expanded CRN and explore the funded projects, visit asapcrn.org